Increased levels of intestinal bile acids (BAs) are a risk factor for colorectal cancer (CRC). Here, we show that the convergence of dietary factors (high-fat diet) and dysregulated WNT signaling (APC mutation) alters BA profiles to drive malignant transformations in Lgr5-expressing (Lgr5 + ) cancer stem cells and promote an adenoma-to-adenocarcinoma progression. Mechanistically, we show that BAs that antagonize intestinal farnesoid X receptor (FXR) function, including tauro-β-muricholic acid (T-βMCA) and deoxycholic acid (DCA), induce proliferation and DNA damage in Lgr5 + cells. Conversely, selective activation of intestinal FXR can restrict abnormal Lgr5 + cell growth and curtail CRC progression. This unexpected role for FXR in coordinating intestinal self-renewal with BA levels implicates FXR as a potential therapeutic target for CRC. The progression of colorectal cancer is fueled by the bile-acid-dependent inhibition of the receptor FXR.
- BA-FXR axis
- Lgr5 intestinal stem cells
- colon cancer progression
- genetic and dietary risk factors
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)